ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 4.580
+0.150 (3.39%)
Feb 13, 2026, 4:08 PM HKT
-18.65% (1Y)
| Market Cap | 1.98B -3.5% |
| Revenue (ttm) | 134.60M +1,584.9% |
| Net Income | -331.67M |
| EPS | -0.84 |
| Shares Out | 431.51M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 861,200 |
| Average Volume | 1,651,344 |
| Open | 4.580 |
| Previous Close | 4.430 |
| Day's Range | 4.340 - 4.580 |
| 52-Week Range | 4.010 - 16.800 |
| Beta | 1.04 |
| RSI | 40.85 |
| Earnings Date | Mar 25, 2026 |